Global Alfuzosin Hydrochloride Sustained Release Tablets Market Growth 2026-2032
The global Alfuzosin Hydrochloride Sustained Release Tablets market size is predicted to grow from US$ 364 million in 2025 to US$ 494 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.
Alfuzosin Hydrochloride Extended-Release Tablets are finished prescription oral solid-dose products containing alfuzosin hydrochloride as the sole active ingredient and using a documented sustained, extended, prolonged or modified-release mechanism. The market includes nationally approved 5 mg, 10 mg and other sustained-release strengths; originator brands, branded generics and unbranded generics; multilayer, hydrophilic-matrix, hydrophobic-matrix and mixed-matrix tablets; and blister, bottle and institutional packs sold through retail pharmacies, hospital pharmacies, mail-order pharmacies and public-procurement channels. Immediate-release alfuzosin tablets, active pharmaceutical ingredient, fixed-dose combinations, other alpha blockers, pharmacy dispensing margins, diagnostic services, procedures and clinical-trial supply are excluded. In 2025, the product global weighted average selling price of approximately US$0.39 per tablet, global sales volume of approximately 955 million tablets, and an average gross margin of about 52%. Upstream activities mainly include the production of alfuzosin hydrochloride API, sustained-release matrix materials, binders, fillers, lubricants, coating materials, and pharmaceutical packaging materials. Midstream activities include formulation development, granulation, tableting, coating, dissolution testing, stability testing, bioequivalence studies, regulatory filing, packaging, and batch release. Downstream customers mainly include pharmaceutical wholesalers, retail pharmacies, hospital pharmacies, public procurement agencies, hospitals, and clinics.
Demand is supported by population aging, wider diagnosis of lower urinary tract symptoms and continued use of alpha-blocker therapy for benign prostatic hyperplasia. Once-daily extended-release tablets offer a simpler regimen than immediate-release tablets requiring multiple daily doses.
Unit-volume growth is expected to remain faster than revenue growth. Generic approvals, hospital tenders and public-procurement programs increase access but also reduce the weighted manufacturer selling price.
The 10 mg once-daily formulation is the principal commercial form in the United States and many European markets. Some countries retain 5 mg prolonged-release products administered twice daily, creating differences in prescription volume and tablet consumption.
Modified-release manufacturing presents a higher technical barrier than ordinary immediate-release tablets. Release architecture, food effect, dissolution profiles, stability and bioequivalence must remain consistent during commercial scale-up and post-approval changes.
Administration requirements affect adherence. Current labels generally require the tablet to be swallowed whole, and many products are taken with food or after the same meal each day. Crushing or chewing may alter the intended release profile.
Commercial competition comes from tamsulosin, silodosin and other alpha blockers, as well as five-alpha-reductase inhibitors, tadalafil and fixed-dose treatment strategies. These alternatives limit the share that alfuzosin can obtain from growth in the broader benign prostatic hyperplasia population.
Important commercial and regulatory considerations include postural hypotension, syncope, hepatic impairment, interactions with strong metabolic inhibitors, interval-prolongation caution and disclosure before cataract surgery. These factors influence patient selection, formulary decisions and promotional boundaries.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Alfuzosin Hydrochloride Sustained Release Tablets Industry Forecast” looks at past sales and reviews total world Alfuzosin Hydrochloride Sustained Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Alfuzosin Hydrochloride Sustained Release Tablets sales for 2026 through 2032. With Alfuzosin Hydrochloride Sustained Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alfuzosin Hydrochloride Sustained Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Alfuzosin Hydrochloride Sustained Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alfuzosin Hydrochloride Sustained Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alfuzosin Hydrochloride Sustained Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alfuzosin Hydrochloride Sustained Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alfuzosin Hydrochloride Sustained Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Alfuzosin Hydrochloride Sustained Release Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Alfuzosin Hydrochloride Extended-Release Tablets are finished prescription oral solid-dose products containing alfuzosin hydrochloride as the sole active ingredient and using a documented sustained, extended, prolonged or modified-release mechanism. The market includes nationally approved 5 mg, 10 mg and other sustained-release strengths; originator brands, branded generics and unbranded generics; multilayer, hydrophilic-matrix, hydrophobic-matrix and mixed-matrix tablets; and blister, bottle and institutional packs sold through retail pharmacies, hospital pharmacies, mail-order pharmacies and public-procurement channels. Immediate-release alfuzosin tablets, active pharmaceutical ingredient, fixed-dose combinations, other alpha blockers, pharmacy dispensing margins, diagnostic services, procedures and clinical-trial supply are excluded. In 2025, the product global weighted average selling price of approximately US$0.39 per tablet, global sales volume of approximately 955 million tablets, and an average gross margin of about 52%. Upstream activities mainly include the production of alfuzosin hydrochloride API, sustained-release matrix materials, binders, fillers, lubricants, coating materials, and pharmaceutical packaging materials. Midstream activities include formulation development, granulation, tableting, coating, dissolution testing, stability testing, bioequivalence studies, regulatory filing, packaging, and batch release. Downstream customers mainly include pharmaceutical wholesalers, retail pharmacies, hospital pharmacies, public procurement agencies, hospitals, and clinics.
Demand is supported by population aging, wider diagnosis of lower urinary tract symptoms and continued use of alpha-blocker therapy for benign prostatic hyperplasia. Once-daily extended-release tablets offer a simpler regimen than immediate-release tablets requiring multiple daily doses.
Unit-volume growth is expected to remain faster than revenue growth. Generic approvals, hospital tenders and public-procurement programs increase access but also reduce the weighted manufacturer selling price.
The 10 mg once-daily formulation is the principal commercial form in the United States and many European markets. Some countries retain 5 mg prolonged-release products administered twice daily, creating differences in prescription volume and tablet consumption.
Modified-release manufacturing presents a higher technical barrier than ordinary immediate-release tablets. Release architecture, food effect, dissolution profiles, stability and bioequivalence must remain consistent during commercial scale-up and post-approval changes.
Administration requirements affect adherence. Current labels generally require the tablet to be swallowed whole, and many products are taken with food or after the same meal each day. Crushing or chewing may alter the intended release profile.
Commercial competition comes from tamsulosin, silodosin and other alpha blockers, as well as five-alpha-reductase inhibitors, tadalafil and fixed-dose treatment strategies. These alternatives limit the share that alfuzosin can obtain from growth in the broader benign prostatic hyperplasia population.
Important commercial and regulatory considerations include postural hypotension, syncope, hepatic impairment, interactions with strong metabolic inhibitors, interval-prolongation caution and disclosure before cataract surgery. These factors influence patient selection, formulary decisions and promotional boundaries.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Alfuzosin Hydrochloride Sustained Release Tablets Industry Forecast” looks at past sales and reviews total world Alfuzosin Hydrochloride Sustained Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Alfuzosin Hydrochloride Sustained Release Tablets sales for 2026 through 2032. With Alfuzosin Hydrochloride Sustained Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alfuzosin Hydrochloride Sustained Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Alfuzosin Hydrochloride Sustained Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alfuzosin Hydrochloride Sustained Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alfuzosin Hydrochloride Sustained Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alfuzosin Hydrochloride Sustained Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alfuzosin Hydrochloride Sustained Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Alfuzosin Hydrochloride Sustained Release Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- 2.5mg
- 5mg
- 10mg
Segmentation by Prescription Duration:
- Up to 30 Days
- 31–90 Days
- Above 90 Days
Segmentation by Brand Positioning:
- Originator Premium Brand
- Regional Branded Generic
- Standard Retail Generic
- Institutional Tender Generic
Segmentation by Application:
- Hospital
- Clinic
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- ADVANZ Pharma
- Apotex Inc.
- Cipla Limited
- Sun Pharmaceutical Industries Limited
- Unichem Laboratories Limited
- Aurobindo Pharma Limited
- Wockhardt Limited
- Rising Pharma Holdings, Inc.
- Zentiva Group, a.s.
- Taj Pharmaceuticals Limited
- Exelan Pharmaceuticals, Inc.
- Lunan Better Pharmaceutical Co., Ltd.
- Anxo Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Alfuzosin Hydrochloride Sustained Release Tablets market?
- What factors are driving Alfuzosin Hydrochloride Sustained Release Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Alfuzosin Hydrochloride Sustained Release Tablets market opportunities vary by end market size?
- How does Alfuzosin Hydrochloride Sustained Release Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Alfuzosin Hydrochloride Sustained Release Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Alfuzosin Hydrochloride Sustained Release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Type
2.2.1 2.5mg
2.2.2 5mg
2.2.3 10mg
2.2.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
2.2.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Type (2021-2026)
2.3 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Prescription Duration
2.3.1 Up to 30 Days
2.3.2 31–90 Days
2.3.3 Above 90 Days
2.3.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Prescription Duration
2.3.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Prescription Duration (2021-2026)
2.3.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Prescription Duration (2021-2026)
2.3.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Prescription Duration (2021-2026)
2.4 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Brand Positioning
2.4.1 Originator Premium Brand
2.4.2 Regional Branded Generic
2.4.3 Standard Retail Generic
2.4.4 Institutional Tender Generic
2.4.5 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Brand Positioning
2.4.5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Brand Positioning (2021-2026)
2.4.5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Brand Positioning (2021-2026)
2.4.5.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Brand Positioning (2021-2026)
2.5 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
2.5.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2021-2026)
2.5.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Breakdown Data by Company
3.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company (2021-2026)
3.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Company
3.4 Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Product Location Distribution
3.4.2 Players Alfuzosin Hydrochloride Sustained Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALFUZOSIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.4 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.5 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.6 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country
5.1.1 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026)
5.1.2 Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026)
5.2 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
5.3 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region
6.1.1 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2021-2026)
6.1.2 APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2021-2026)
6.2 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
6.3 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets by Country
7.1.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026)
7.1.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026)
7.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
7.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets by Country
8.1.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
10.3 Manufacturing Process Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
10.4 Industry Chain Structure of Alfuzosin Hydrochloride Sustained Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alfuzosin Hydrochloride Sustained Release Tablets Distributors
11.3 Alfuzosin Hydrochloride Sustained Release Tablets Customer
12 WORLD FORECAST REVIEW FOR ALFUZOSIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Forecast by Region
12.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Region (2027-2032)
12.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Type (2027-2032)
12.7 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.1.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 ADVANZ Pharma
13.2.1 ADVANZ Pharma Company Information
13.2.2 ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.2.3 ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 ADVANZ Pharma Main Business Overview
13.2.5 ADVANZ Pharma Latest Developments
13.3 Apotex Inc.
13.3.1 Apotex Inc. Company Information
13.3.2 Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.3.3 Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Apotex Inc. Main Business Overview
13.3.5 Apotex Inc. Latest Developments
13.4 Cipla Limited
13.4.1 Cipla Limited Company Information
13.4.2 Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.4.3 Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Limited Main Business Overview
13.4.5 Cipla Limited Latest Developments
13.5 Sun Pharmaceutical Industries Limited
13.5.1 Sun Pharmaceutical Industries Limited Company Information
13.5.2 Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sun Pharmaceutical Industries Limited Main Business Overview
13.5.5 Sun Pharmaceutical Industries Limited Latest Developments
13.6 Unichem Laboratories Limited
13.6.1 Unichem Laboratories Limited Company Information
13.6.2 Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.6.3 Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Unichem Laboratories Limited Main Business Overview
13.6.5 Unichem Laboratories Limited Latest Developments
13.7 Aurobindo Pharma Limited
13.7.1 Aurobindo Pharma Limited Company Information
13.7.2 Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Aurobindo Pharma Limited Main Business Overview
13.7.5 Aurobindo Pharma Limited Latest Developments
13.8 Wockhardt Limited
13.8.1 Wockhardt Limited Company Information
13.8.2 Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.8.3 Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wockhardt Limited Main Business Overview
13.8.5 Wockhardt Limited Latest Developments
13.9 Rising Pharma Holdings, Inc.
13.9.1 Rising Pharma Holdings, Inc. Company Information
13.9.2 Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.9.3 Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Rising Pharma Holdings, Inc. Main Business Overview
13.9.5 Rising Pharma Holdings, Inc. Latest Developments
13.10 Zentiva Group, a.s.
13.10.1 Zentiva Group, a.s. Company Information
13.10.2 Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.10.3 Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zentiva Group, a.s. Main Business Overview
13.10.5 Zentiva Group, a.s. Latest Developments
13.11 Taj Pharmaceuticals Limited
13.11.1 Taj Pharmaceuticals Limited Company Information
13.11.2 Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.11.3 Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Taj Pharmaceuticals Limited Main Business Overview
13.11.5 Taj Pharmaceuticals Limited Latest Developments
13.12 Exelan Pharmaceuticals, Inc.
13.12.1 Exelan Pharmaceuticals, Inc. Company Information
13.12.2 Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.12.3 Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Exelan Pharmaceuticals, Inc. Main Business Overview
13.12.5 Exelan Pharmaceuticals, Inc. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Anxo Pharmaceutical Co., Ltd.
13.14.1 Anxo Pharmaceutical Co., Ltd. Company Information
13.14.2 Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.14.3 Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Anxo Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Anxo Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Alfuzosin Hydrochloride Sustained Release Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Alfuzosin Hydrochloride Sustained Release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Type
2.2.1 2.5mg
2.2.2 5mg
2.2.3 10mg
2.2.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type
2.2.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Type (2021-2026)
2.3 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Prescription Duration
2.3.1 Up to 30 Days
2.3.2 31–90 Days
2.3.3 Above 90 Days
2.3.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Prescription Duration
2.3.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Prescription Duration (2021-2026)
2.3.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Prescription Duration (2021-2026)
2.3.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Prescription Duration (2021-2026)
2.4 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Brand Positioning
2.4.1 Originator Premium Brand
2.4.2 Regional Branded Generic
2.4.3 Standard Retail Generic
2.4.4 Institutional Tender Generic
2.4.5 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Brand Positioning
2.4.5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Brand Positioning (2021-2026)
2.4.5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Brand Positioning (2021-2026)
2.4.5.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Brand Positioning (2021-2026)
2.5 Alfuzosin Hydrochloride Sustained Release Tablets Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Other
2.5.4 Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application
2.5.4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2021-2026)
2.5.4.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Breakdown Data by Company
3.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company (2021-2026)
3.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Company
3.4 Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Product Location Distribution
3.4.2 Players Alfuzosin Hydrochloride Sustained Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALFUZOSIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.4 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.5 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
4.6 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country
5.1.1 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026)
5.1.2 Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026)
5.2 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
5.3 Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region
6.1.1 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2021-2026)
6.1.2 APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2021-2026)
6.2 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
6.3 APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets by Country
7.1.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026)
7.1.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026)
7.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
7.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets by Country
8.1.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
10.3 Manufacturing Process Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
10.4 Industry Chain Structure of Alfuzosin Hydrochloride Sustained Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alfuzosin Hydrochloride Sustained Release Tablets Distributors
11.3 Alfuzosin Hydrochloride Sustained Release Tablets Customer
12 WORLD FORECAST REVIEW FOR ALFUZOSIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size Forecast by Region
12.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Region (2027-2032)
12.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Type (2027-2032)
12.7 Global Alfuzosin Hydrochloride Sustained Release Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.1.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 ADVANZ Pharma
13.2.1 ADVANZ Pharma Company Information
13.2.2 ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.2.3 ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 ADVANZ Pharma Main Business Overview
13.2.5 ADVANZ Pharma Latest Developments
13.3 Apotex Inc.
13.3.1 Apotex Inc. Company Information
13.3.2 Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.3.3 Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Apotex Inc. Main Business Overview
13.3.5 Apotex Inc. Latest Developments
13.4 Cipla Limited
13.4.1 Cipla Limited Company Information
13.4.2 Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.4.3 Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Limited Main Business Overview
13.4.5 Cipla Limited Latest Developments
13.5 Sun Pharmaceutical Industries Limited
13.5.1 Sun Pharmaceutical Industries Limited Company Information
13.5.2 Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sun Pharmaceutical Industries Limited Main Business Overview
13.5.5 Sun Pharmaceutical Industries Limited Latest Developments
13.6 Unichem Laboratories Limited
13.6.1 Unichem Laboratories Limited Company Information
13.6.2 Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.6.3 Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Unichem Laboratories Limited Main Business Overview
13.6.5 Unichem Laboratories Limited Latest Developments
13.7 Aurobindo Pharma Limited
13.7.1 Aurobindo Pharma Limited Company Information
13.7.2 Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Aurobindo Pharma Limited Main Business Overview
13.7.5 Aurobindo Pharma Limited Latest Developments
13.8 Wockhardt Limited
13.8.1 Wockhardt Limited Company Information
13.8.2 Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.8.3 Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wockhardt Limited Main Business Overview
13.8.5 Wockhardt Limited Latest Developments
13.9 Rising Pharma Holdings, Inc.
13.9.1 Rising Pharma Holdings, Inc. Company Information
13.9.2 Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.9.3 Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Rising Pharma Holdings, Inc. Main Business Overview
13.9.5 Rising Pharma Holdings, Inc. Latest Developments
13.10 Zentiva Group, a.s.
13.10.1 Zentiva Group, a.s. Company Information
13.10.2 Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.10.3 Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Zentiva Group, a.s. Main Business Overview
13.10.5 Zentiva Group, a.s. Latest Developments
13.11 Taj Pharmaceuticals Limited
13.11.1 Taj Pharmaceuticals Limited Company Information
13.11.2 Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.11.3 Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Taj Pharmaceuticals Limited Main Business Overview
13.11.5 Taj Pharmaceuticals Limited Latest Developments
13.12 Exelan Pharmaceuticals, Inc.
13.12.1 Exelan Pharmaceuticals, Inc. Company Information
13.12.2 Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.12.3 Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Exelan Pharmaceuticals, Inc. Main Business Overview
13.12.5 Exelan Pharmaceuticals, Inc. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Anxo Pharmaceutical Co., Ltd.
13.14.1 Anxo Pharmaceutical Co., Ltd. Company Information
13.14.2 Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
13.14.3 Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Anxo Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Anxo Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2.5mg
Table 4. Major Players of 5mg
Table 5. Major Players of 10mg
Table 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Type (2021-2026) & (US$/tablet)
Table 11. Major Players of Up to 30 Days
Table 12. Major Players of 31–90 Days
Table 13. Major Players of Above 90 Days
Table 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Prescription Duration (2021-2026) & (Million tablets)
Table 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Prescription Duration (2021-2026)
Table 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Prescription Duration (2021-2026) & ($ million)
Table 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Prescription Duration (2021-2026)
Table 18. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Prescription Duration (2021-2026) & (US$/tablet)
Table 19. Major Players of Originator Premium Brand
Table 20. Major Players of Regional Branded Generic
Table 21. Major Players of Standard Retail Generic
Table 22. Major Players of Institutional Tender Generic
Table 23. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Brand Positioning (2021-2026) & (Million tablets)
Table 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Brand Positioning (2021-2026)
Table 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Brand Positioning (2021-2026) & ($ million)
Table 26. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Brand Positioning (2021-2026)
Table 27. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Brand Positioning (2021-2026) & (US$/tablet)
Table 28. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale by Application (2021-2026) & (Million tablets)
Table 29. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2021-2026)
Table 30. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2021-2026) & ($ million)
Table 31. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2021-2026)
Table 32. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Application (2021-2026) & (US$/tablet)
Table 33. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Company (2021-2026) & (Million tablets)
Table 34. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company (2021-2026)
Table 35. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company (2021-2026)
Table 37. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Company (2021-2026) & (US$/tablet)
Table 38. Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Producing Area Distribution and Sales Area
Table 39. Players Alfuzosin Hydrochloride Sustained Release Tablets Products Offered
Table 40. Alfuzosin Hydrochloride Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Region (2021-2026) & (Million tablets)
Table 44. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share Geographic Region (2021-2026)
Table 45. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country/Region (2021-2026) & (Million tablets)
Table 48. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country/Region (2021-2026)
Table 49. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026) & (Million tablets)
Table 52. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2021-2026)
Table 53. Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 55. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 56. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2021-2026) & (Million tablets)
Table 57. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2021-2026)
Table 58. APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 60. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 61. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026) & (Million tablets)
Table 62. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 64. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 65. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026) & (Million tablets)
Table 66. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 68. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 69. Key Market Drivers & Growth Opportunities of Alfuzosin Hydrochloride Sustained Release Tablets
Table 70. Key Market Challenges & Risks of Alfuzosin Hydrochloride Sustained Release Tablets
Table 71. Key Industry Trends of Alfuzosin Hydrochloride Sustained Release Tablets
Table 72. Alfuzosin Hydrochloride Sustained Release Tablets Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Alfuzosin Hydrochloride Sustained Release Tablets Distributors List
Table 75. Alfuzosin Hydrochloride Sustained Release Tablets Customer List
Table 76. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Region (2027-2032) & (Million tablets)
Table 77. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Country (2027-2032) & (Million tablets)
Table 79. Americas Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Region (2027-2032) & (Million tablets)
Table 81. APAC Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Country (2027-2032) & (Million tablets)
Table 83. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Country (2027-2032) & (Million tablets)
Table 85. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Type (2027-2032) & (Million tablets)
Table 87. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Application (2027-2032) & (Million tablets)
Table 89. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Sanofi Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 92. Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. ADVANZ Pharma Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 96. ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 97. ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 98. ADVANZ Pharma Main Business
Table 99. ADVANZ Pharma Latest Developments
Table 100. Apotex Inc. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 101. Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 102. Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 103. Apotex Inc. Main Business
Table 104. Apotex Inc. Latest Developments
Table 105. Cipla Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 106. Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 107. Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 108. Cipla Limited Main Business
Table 109. Cipla Limited Latest Developments
Table 110. Sun Pharmaceutical Industries Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 111. Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 112. Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 113. Sun Pharmaceutical Industries Limited Main Business
Table 114. Sun Pharmaceutical Industries Limited Latest Developments
Table 115. Unichem Laboratories Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 116. Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 117. Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 118. Unichem Laboratories Limited Main Business
Table 119. Unichem Laboratories Limited Latest Developments
Table 120. Aurobindo Pharma Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 121. Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 122. Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 123. Aurobindo Pharma Limited Main Business
Table 124. Aurobindo Pharma Limited Latest Developments
Table 125. Wockhardt Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 126. Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 127. Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 128. Wockhardt Limited Main Business
Table 129. Wockhardt Limited Latest Developments
Table 130. Rising Pharma Holdings, Inc. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 131. Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 132. Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 133. Rising Pharma Holdings, Inc. Main Business
Table 134. Rising Pharma Holdings, Inc. Latest Developments
Table 135. Zentiva Group, a.s. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 136. Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 137. Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 138. Zentiva Group, a.s. Main Business
Table 139. Zentiva Group, a.s. Latest Developments
Table 140. Taj Pharmaceuticals Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 141. Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 142. Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 143. Taj Pharmaceuticals Limited Main Business
Table 144. Taj Pharmaceuticals Limited Latest Developments
Table 145. Exelan Pharmaceuticals, Inc. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 146. Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 147. Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 148. Exelan Pharmaceuticals, Inc. Main Business
Table 149. Exelan Pharmaceuticals, Inc. Latest Developments
Table 150. Lunan Better Pharmaceutical Co., Ltd. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 151. Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 152. Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 153. Lunan Better Pharmaceutical Co., Ltd. Main Business
Table 154. Lunan Better Pharmaceutical Co., Ltd. Latest Developments
Table 155. Anxo Pharmaceutical Co., Ltd. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 156. Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 157. Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 158. Anxo Pharmaceutical Co., Ltd. Main Business
Table 159. Anxo Pharmaceutical Co., Ltd. Latest Developments
Table 1. Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Alfuzosin Hydrochloride Sustained Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2.5mg
Table 4. Major Players of 5mg
Table 5. Major Players of 10mg
Table 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Type (2021-2026) & (US$/tablet)
Table 11. Major Players of Up to 30 Days
Table 12. Major Players of 31–90 Days
Table 13. Major Players of Above 90 Days
Table 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Prescription Duration (2021-2026) & (Million tablets)
Table 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Prescription Duration (2021-2026)
Table 16. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Prescription Duration (2021-2026) & ($ million)
Table 17. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Prescription Duration (2021-2026)
Table 18. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Prescription Duration (2021-2026) & (US$/tablet)
Table 19. Major Players of Originator Premium Brand
Table 20. Major Players of Regional Branded Generic
Table 21. Major Players of Standard Retail Generic
Table 22. Major Players of Institutional Tender Generic
Table 23. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Brand Positioning (2021-2026) & (Million tablets)
Table 24. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Brand Positioning (2021-2026)
Table 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Brand Positioning (2021-2026) & ($ million)
Table 26. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Brand Positioning (2021-2026)
Table 27. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Brand Positioning (2021-2026) & (US$/tablet)
Table 28. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale by Application (2021-2026) & (Million tablets)
Table 29. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2021-2026)
Table 30. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Application (2021-2026) & ($ million)
Table 31. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application (2021-2026)
Table 32. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Application (2021-2026) & (US$/tablet)
Table 33. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Company (2021-2026) & (Million tablets)
Table 34. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company (2021-2026)
Table 35. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company (2021-2026)
Table 37. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Price by Company (2021-2026) & (US$/tablet)
Table 38. Key Manufacturers Alfuzosin Hydrochloride Sustained Release Tablets Producing Area Distribution and Sales Area
Table 39. Players Alfuzosin Hydrochloride Sustained Release Tablets Products Offered
Table 40. Alfuzosin Hydrochloride Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Region (2021-2026) & (Million tablets)
Table 44. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share Geographic Region (2021-2026)
Table 45. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country/Region (2021-2026) & (Million tablets)
Table 48. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country/Region (2021-2026)
Table 49. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026) & (Million tablets)
Table 52. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2021-2026)
Table 53. Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 55. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 56. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Region (2021-2026) & (Million tablets)
Table 57. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region (2021-2026)
Table 58. APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 60. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 61. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026) & (Million tablets)
Table 62. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 64. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 65. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Country (2021-2026) & (Million tablets)
Table 66. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Type (2021-2026) & (Million tablets)
Table 68. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales by Application (2021-2026) & (Million tablets)
Table 69. Key Market Drivers & Growth Opportunities of Alfuzosin Hydrochloride Sustained Release Tablets
Table 70. Key Market Challenges & Risks of Alfuzosin Hydrochloride Sustained Release Tablets
Table 71. Key Industry Trends of Alfuzosin Hydrochloride Sustained Release Tablets
Table 72. Alfuzosin Hydrochloride Sustained Release Tablets Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Alfuzosin Hydrochloride Sustained Release Tablets Distributors List
Table 75. Alfuzosin Hydrochloride Sustained Release Tablets Customer List
Table 76. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Region (2027-2032) & (Million tablets)
Table 77. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Country (2027-2032) & (Million tablets)
Table 79. Americas Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Region (2027-2032) & (Million tablets)
Table 81. APAC Alfuzosin Hydrochloride Sustained Release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Country (2027-2032) & (Million tablets)
Table 83. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Country (2027-2032) & (Million tablets)
Table 85. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Type (2027-2032) & (Million tablets)
Table 87. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Forecast by Application (2027-2032) & (Million tablets)
Table 89. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Sanofi Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 92. Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. ADVANZ Pharma Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 96. ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 97. ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 98. ADVANZ Pharma Main Business
Table 99. ADVANZ Pharma Latest Developments
Table 100. Apotex Inc. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 101. Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 102. Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 103. Apotex Inc. Main Business
Table 104. Apotex Inc. Latest Developments
Table 105. Cipla Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 106. Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 107. Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 108. Cipla Limited Main Business
Table 109. Cipla Limited Latest Developments
Table 110. Sun Pharmaceutical Industries Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 111. Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 112. Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 113. Sun Pharmaceutical Industries Limited Main Business
Table 114. Sun Pharmaceutical Industries Limited Latest Developments
Table 115. Unichem Laboratories Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 116. Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 117. Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 118. Unichem Laboratories Limited Main Business
Table 119. Unichem Laboratories Limited Latest Developments
Table 120. Aurobindo Pharma Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 121. Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 122. Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 123. Aurobindo Pharma Limited Main Business
Table 124. Aurobindo Pharma Limited Latest Developments
Table 125. Wockhardt Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 126. Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 127. Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 128. Wockhardt Limited Main Business
Table 129. Wockhardt Limited Latest Developments
Table 130. Rising Pharma Holdings, Inc. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 131. Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 132. Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 133. Rising Pharma Holdings, Inc. Main Business
Table 134. Rising Pharma Holdings, Inc. Latest Developments
Table 135. Zentiva Group, a.s. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 136. Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 137. Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 138. Zentiva Group, a.s. Main Business
Table 139. Zentiva Group, a.s. Latest Developments
Table 140. Taj Pharmaceuticals Limited Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 141. Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 142. Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 143. Taj Pharmaceuticals Limited Main Business
Table 144. Taj Pharmaceuticals Limited Latest Developments
Table 145. Exelan Pharmaceuticals, Inc. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 146. Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 147. Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 148. Exelan Pharmaceuticals, Inc. Main Business
Table 149. Exelan Pharmaceuticals, Inc. Latest Developments
Table 150. Lunan Better Pharmaceutical Co., Ltd. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 151. Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 152. Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 153. Lunan Better Pharmaceutical Co., Ltd. Main Business
Table 154. Lunan Better Pharmaceutical Co., Ltd. Latest Developments
Table 155. Anxo Pharmaceutical Co., Ltd. Basic Information, Alfuzosin Hydrochloride Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 156. Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product Portfolios and Specifications
Table 157. Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales (Million tablets), Revenue ($ Million), Price (US$/tablet) and Gross Margin (2021-2026)
Table 158. Anxo Pharmaceutical Co., Ltd. Main Business
Table 159. Anxo Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Alfuzosin Hydrochloride Sustained Release Tablets
Figure 2. Alfuzosin Hydrochloride Sustained Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth Rate 2021-2032 (Million tablets)
Figure 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2.5mg
Figure 12. Product Picture of 5mg
Figure 13. Product Picture of 10mg
Figure 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type in 2026
Figure 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Up to 30 Days
Figure 17. Product Picture of 31–90 Days
Figure 18. Product Picture of Above 90 Days
Figure 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Prescription Duration in 2026
Figure 20. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Prescription Duration (2021-2026)
Figure 21. Product Picture of Originator Premium Brand
Figure 22. Product Picture of Regional Branded Generic
Figure 23. Product Picture of Standard Retail Generic
Figure 24. Product Picture of Institutional Tender Generic
Figure 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Brand Positioning in 2026
Figure 26. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Brand Positioning (2021-2026)
Figure 27. Alfuzosin Hydrochloride Sustained Release Tablets Consumed in Hospital
Figure 28. Global Alfuzosin Hydrochloride Sustained Release Tablets Market: Hospital (2021-2026) & (Million tablets)
Figure 29. Alfuzosin Hydrochloride Sustained Release Tablets Consumed in Clinic
Figure 30. Global Alfuzosin Hydrochloride Sustained Release Tablets Market: Clinic (2021-2026) & (Million tablets)
Figure 31. Alfuzosin Hydrochloride Sustained Release Tablets Consumed in Other
Figure 32. Global Alfuzosin Hydrochloride Sustained Release Tablets Market: Other (2021-2026) & (Million tablets)
Figure 33. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2025)
Figure 34. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application in 2025
Figure 35. Alfuzosin Hydrochloride Sustained Release Tablets Sales by Company in 2025 (Million tablets)
Figure 36. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company in 2025
Figure 37. Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company in 2025 ($ millions)
Figure 38. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company in 2025
Figure 39. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 42. Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 43. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 44. APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 45. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 46. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 48. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 49. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country in 2025
Figure 50. Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2021-2026)
Figure 51. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 52. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 53. United States Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region in 2025
Figure 58. APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2021-2026)
Figure 59. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 60. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 61. China Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. India Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country in 2025
Figure 69. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2021-2026)
Figure 70. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 71. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 72. Germany Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. France Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 80. Egypt Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Alfuzosin Hydrochloride Sustained Release Tablets in 2026
Figure 86. Manufacturing Process Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
Figure 87. Industry Chain Structure of Alfuzosin Hydrochloride Sustained Release Tablets
Figure 88. Channels of Distribution
Figure 89. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Forecast by Region (2027-2032)
Figure 90. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Alfuzosin Hydrochloride Sustained Release Tablets
Figure 2. Alfuzosin Hydrochloride Sustained Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Growth Rate 2021-2032 (Million tablets)
Figure 7. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Alfuzosin Hydrochloride Sustained Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2.5mg
Figure 12. Product Picture of 5mg
Figure 13. Product Picture of 10mg
Figure 14. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type in 2026
Figure 15. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Up to 30 Days
Figure 17. Product Picture of 31–90 Days
Figure 18. Product Picture of Above 90 Days
Figure 19. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Prescription Duration in 2026
Figure 20. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Prescription Duration (2021-2026)
Figure 21. Product Picture of Originator Premium Brand
Figure 22. Product Picture of Regional Branded Generic
Figure 23. Product Picture of Standard Retail Generic
Figure 24. Product Picture of Institutional Tender Generic
Figure 25. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Brand Positioning in 2026
Figure 26. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Brand Positioning (2021-2026)
Figure 27. Alfuzosin Hydrochloride Sustained Release Tablets Consumed in Hospital
Figure 28. Global Alfuzosin Hydrochloride Sustained Release Tablets Market: Hospital (2021-2026) & (Million tablets)
Figure 29. Alfuzosin Hydrochloride Sustained Release Tablets Consumed in Clinic
Figure 30. Global Alfuzosin Hydrochloride Sustained Release Tablets Market: Clinic (2021-2026) & (Million tablets)
Figure 31. Alfuzosin Hydrochloride Sustained Release Tablets Consumed in Other
Figure 32. Global Alfuzosin Hydrochloride Sustained Release Tablets Market: Other (2021-2026) & (Million tablets)
Figure 33. Global Alfuzosin Hydrochloride Sustained Release Tablets Sale Market Share by Application (2025)
Figure 34. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Application in 2025
Figure 35. Alfuzosin Hydrochloride Sustained Release Tablets Sales by Company in 2025 (Million tablets)
Figure 36. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Company in 2025
Figure 37. Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Company in 2025 ($ millions)
Figure 38. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Company in 2025
Figure 39. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 42. Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 43. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 44. APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 45. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 46. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales 2021-2026 (Million tablets)
Figure 48. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue 2021-2026 ($ millions)
Figure 49. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country in 2025
Figure 50. Americas Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2021-2026)
Figure 51. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 52. Americas Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 53. United States Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Region in 2025
Figure 58. APAC Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Region (2021-2026)
Figure 59. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 60. APAC Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 61. China Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. India Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country in 2025
Figure 69. Europe Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share by Country (2021-2026)
Figure 70. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 71. Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 72. Germany Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. France Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share by Application (2021-2026)
Figure 80. Egypt Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Alfuzosin Hydrochloride Sustained Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Alfuzosin Hydrochloride Sustained Release Tablets in 2026
Figure 86. Manufacturing Process Analysis of Alfuzosin Hydrochloride Sustained Release Tablets
Figure 87. Industry Chain Structure of Alfuzosin Hydrochloride Sustained Release Tablets
Figure 88. Channels of Distribution
Figure 89. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Forecast by Region (2027-2032)
Figure 90. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue Market Share Forecast by Application (2027-2032)
